Skip to main content
Log in

Primary bone marrow diffuse large B cell lymphoma: a case series and review

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Diffuse large cell lymphoma involving bone marrow is not uncommon, but primary, de novo, bone marrow diffuse large B cell lymphoma (DLBCL) is rare. To understand the clinical features and outcomes of this distinct entity, we collected 12 cases in 5 years from a single-center database. They accounted for 1.16% of lymphoma, or 2.65% of diffuse large B cell lymphoma. Nine cases presented with fever of unknown origin. Lactate dehydrogenase levels were elevated in all but one case. Nine cases belonged to the high-risk group according to their international prognosis indexes (score 4 or 5). Four patients received no chemotherapy, all of whom died within 1 month. Four patients received cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP)-like chemotherapy, and their median survival was 13 months. Finally, four patients received rituximab 375 mg/m2 in addition to CHOP-like chemotherapy. All of them had complete remission and three are still alive without relapse. We concluded that primary bone marrow DLBCL is a rare but distinctive subtype of lymphoma. The prognosis for this entity is poor but rituximab-based treatment is promising for improving its outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Strauchen JA (2003) Primary bone marrow B-cell lymphoma: report of four cases. Mt Sinai J Med 70(2):133–138

    PubMed  Google Scholar 

  2. Kajiura D, Yamashita Y, Mori N (2007) Diffuse large B-cell lymphoma initially manifesting in the bone marrow. Am J Clin Pathol 127(5):762–769

    Article  PubMed  Google Scholar 

  3. Alvares CL, Matutes E, Scully MA, Swansbury J, Min T, Gruszka-Westwood AM, Atkinson S, Hilditch B, Morilla R, Wotherspoon AC, Catovsky D (2004) Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma 45(4):769–775

    Article  PubMed  Google Scholar 

  4. Hishizawa M, Okamoto K, Chonabayashi K, Kaneko H, Watanabe M, Tsudo M (2007) Primary large B-cell lymphoma of the bone marrow. Br J Haematol 136(3):351

    Article  PubMed  Google Scholar 

  5. Wong KF, Chan JK, Ng CS, Chu YC, Li LP, Chan CH (1992) Large cell lymphoma with initial presentation in the bone marrow. Hematol Oncol 10(5):261–271

    Article  PubMed  CAS  Google Scholar 

  6. Staples WG, Getaz EP (1977) Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy. S Afr Med J 52(2):60–63

    PubMed  CAS  Google Scholar 

  7. Bain B, Matutes E, Robinson D, Lampert IA, Brito-Babapulle V, Morilla R, Catovsky D (1991) Leukaemia as a manifestation of large cell lymphoma. Br J Haematol 77(3):301–310

    Article  PubMed  CAS  Google Scholar 

  8. Kong SY, Cho EH, Woo HY, Park Q, Ko YH, Kim SH (2004) De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean. J Korean Med Sci 19(6):815–819

    Article  PubMed  Google Scholar 

  9. Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, Suzumiya J, Murase T, Miura I, Akasaka T, Tamaru J, Suzuki R, Kagami Y, Hirano M, Morishima Y, Ueda R, Shiku H, Nakamura S (2002) De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 99(3):815–821

    Article  PubMed  CAS  Google Scholar 

  10. Yoshida K, Kayano H, Akiba M, Kishimoto K, Takahashi N, Sugahara Y, Kawai N, Matsuda A, Hirashima K, Suzuki T, Bessho M (2002) De novo CD5-positive diffuse large B-cell lymphoma with leukemic dissemination diagnosed by immunohistochemical examinations of bone marrow clot sections. Rinsho Ketsueki 43(10):943–948

    PubMed  Google Scholar 

  11. Anonymous (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329(14):987–994

    Article  Google Scholar 

  12. Aung W, Koslosky W, Chin NW, Pincus MR (1996) Diffuse large cell lymphoma of B-cell type associated with reactive hemophagocytosis. Ann Clin Lab Sci 26(5):433–436

    PubMed  CAS  Google Scholar 

  13. Shimazaki C, Inaba T, Okano A, Hatsuse M, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Tsuda H, Fujita N, Nakagawa M (2001) Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS. Intern Med 40(9):878–882

    Article  PubMed  CAS  Google Scholar 

  14. Shimazaki C, Inaba T, Nakagawa M (2000) B-cell lymphoma-associated hemophagocytic syndrome. Leuk Lymphoma 38(1–2):121–130

    PubMed  CAS  Google Scholar 

  15. Chen WL, Tsai WC, Chao TY, Sheu LF, Chou JM, Kao WY, Chen YC, Ho CL (2009) The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol 89:553–562

    Article  PubMed  Google Scholar 

  16. Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, Kojima M, Miura I, Mori N, Yoshino T, Nakamura S (2007) Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109(2):478–485

    Article  PubMed  CAS  Google Scholar 

  17. Murase T, Nakamura S, Kawauchi K, Matsuzaki H, Sakai C, Inaba T, Nasu K, Tashiro K, Suchi T, Saito H (2000) An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111(3):826–834

    Article  PubMed  CAS  Google Scholar 

  18. Nakamura N, Hashimoto Y, Kuze T, Tasaki K, Sasaki Y, Sato M, Abe M (1999) Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma. Lab Invest 79(8):925–933

    PubMed  CAS  Google Scholar 

  19. Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, Kita K, Shiku H (1998) De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91(4):1145–1151

    PubMed  CAS  Google Scholar 

  20. Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, Suzuki H, Oyama A, Kodera Y, Ueda R, Morishima Y, Nakamura S, Seto M (1999) Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes. Leukemia 13(9):1441–1447

    Article  PubMed  CAS  Google Scholar 

  21. Matolcsy A, Nador RG, Cesarman E, Knowles DM (1998) Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153(5):1609–1614

    Article  PubMed  CAS  Google Scholar 

Download references

Financial supports

This work is supported by the grant DOH99-TD-C-111-006 from the Department of Health, Executive Yuan, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lee-Yung Shih.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, H., Hung, YS., Lin, TL. et al. Primary bone marrow diffuse large B cell lymphoma: a case series and review. Ann Hematol 90, 791–796 (2011). https://doi.org/10.1007/s00277-010-1129-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-1129-4

Keywords

Navigation